Polarization Of Monocytic Myeloid-Derived Suppressor Cells By Hepatitis B Surface Antigen Is Mediated Via Erk/Il-6/Stat3 Signaling Feedback And Restrains The Activation Of T Cells In Chronic Hepatitis B Virus Infection

Zhong Fang,Jin Li,Xiaoyu Yu,Dandan Zhang,Guangxu Ren,Bisheng Shi,Cong Wang,Anna D. Kosinska,Sen Wang,Xiaohui Zhou,Maya Kozlowski,Yunwen Hu,Zhenghong Yuan
DOI: https://doi.org/10.4049/jimmunol.1501362
2015-01-01
Abstract:Chronic hepatitis B virus (HBV) infection is characterized by T cell tolerance to virus. Although inhibition of T cell responses by myeloid-derived suppressor cells (MDSCs) has been observed in patients with chronic hepatitis B (CHB), the mechanism for expansion of MDSCs remains ambiguous. In this study, a significant increased frequency of monocytic MDSCs (mMDSCs) was shown positively correlated to level of HBsAg in the patients with CHB. We further found hepatitis B surface Ag (HBsAg) efficiently promoted differentiation of mMDSCs in vitro, and monocytes in PBMCs performed as the progenitors. This required the activation of ERK/IL-6/STAT3 signaling feedback. Importantly, the mMDSCs polarized by HBsAg in vitro acquired the ability to suppress T cell activation. Additionally, treatment of all-trans retinoic acid, an MDSC-targeted drug, restored the proliferation and IFN-gamma production by HBV-specific CD4(+) and CD8(+) T cells in PBMCs from patients with CHB and prevented increase of viral load in mouse model. In summary, HBsAg maintains HBV persistence and suppresses T cell responses by promoting differentiation of monocytes into mMDSCs. A therapy aimed at the abrogation of MDSCs may help to disrupt immune suppression in patients with CHB.
What problem does this paper attempt to address?